Diagnos Inc.

Overview

Compare with another stock.

• TickerDGNOF on OTC¹
• HeadquartersBrossard, Canada¹
• Incorporated inCanada (Federal Level)²
• Business address7005 Taschereau Boulevard, Suite 340, Brossard, A8 J4Z 1A7²
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive Officer, DirectorAndre Larente named Jan 6, 2026³
• Executive OfficerMarc-Andre Massue named Jan 6, 2026³
• Executive Officer, DirectorPhilippe Couillard named Jan 6, 2026³
• Executive OfficerYves-Stephane Couture named Jan 6, 2026³
• DirectorMichael Braeuel named Jan 6, 2026³
• DirectorRobert Dunn named Jan 6, 2026³

Filings

1 filings to the SEC since October 2021: 1 private raises. The latest 1:

1. Jan 6, 2026D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Dec 5, 2025Raised $202,254 in a private offering of equity³ Form D: $4.1 million offered in all Form D

SEC filer profile

How Diagnos Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARDiagnos Inc.¹
• CIK0001790693
• Incorporated inCanada (Federal Level)¹
• Fiscal year endsMarch 31¹
• Business address7005 Taschereau Boulevard, Suite 340, Brossard, A8 J4Z 1A7¹
• Phone450 678-8882¹
• On EDGAR sinceOct 9, 2019¹
• Filings2 in all: D (2)¹